LINCOLNPharmaceuticals
Lincoln Pharmaceuticals Ltd — Quarterly Results & Earnings
₹564.95
-2.30%
Profit Growth YoY-24.12%Latest quarter
Sales Growth YoY1.33%Latest quarter
Sales CAGR 5Y10.03%5 year compound
Profit CAGR 5Y9.50%5 year compound
📋
Quarterly Performance
YoY Profit Growth-24.12%
🔴 Significant decline
YoY Sales Growth+1.33%
📈 Moderate growth
OPM 5Y Average
18.17%Operating profit margin
EPS Growth 5Y
9.47%Interest Coverage
71.86Higher = safer debt servicing
ROE
12.82%ROCE
17.28%💡
Growth Analysis
Lincoln Pharmaceuticals Ltd reported YoY profit growth of -24.12% and revenue growth of 1.33% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 10.03% and profits at 9.50% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Lincoln Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.